Literature DB >> 11002255

Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene.

F Morfin1, D Thouvenot, M Aymard, G Souillet.   

Abstract

HSV infections are treated efficiently and prevented by acyclovir, although resistant strains have been reported. Resistance to acyclovir involves mainly mutations in the viral gene encoding thymidine kinase; mutations may lead to an altered or, more frequently, deficient TK. These acyclovir-resistant TK deficient strains are not able to reactivate from a latent infection in an experimental model, compared to TK positive strains. A case is reported of a bone marrow transplant child who developed HSV infection at 11 days post-transplantation. Acyclovir-resistant HSV 1 was isolated on day 19 post-transplantation. The patient was cured of his infection. A resistant virus was detected 20 months later that harboured the same TK gene mutation as the first resistant virus. This mutation is an insertion of one guanine in a homopolymer repeat of seven guanines located at codon 146 of TK. It has previously been reported and associated with the expression of a deficient TK activity and the ability to reactivate in mice. These results corroborate the clinical relevance of this mutation, which is associated with acyclovir-resistant recurrent infections in humans. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11002255

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

Review 1.  Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance.

Authors:  Anthony Griffiths
Journal:  Drug Resist Updat       Date:  2011-09-22       Impact factor: 18.500

Review 2.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia.

Authors:  Michael I Besecker; Caroline L Furness; Donald M Coen; Anthony Griffiths
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

4.  Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency.

Authors:  Anthony Griffiths; Shun-Hua Chen; Brian C Horsburgh; Donald M Coen
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Longitudinal Characterization of Herpes Simplex Virus (HSV) Isolates Acquired From Different Sites in an Immune-Compromised Child: A New HSV Thymidine Kinase Mutation Associated With Resistance.

Authors:  Andrew H Karaba; Laura K Cohen; Taly Glaubach; Sarah J Kopp; Jennifer L Reichek; Hawke H Yoon; Xiaotian T Zheng; William J Muller
Journal:  J Pediatric Infect Dis Soc       Date:  2012-05-03       Impact factor: 3.164

Review 6.  Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy.

Authors:  Teresa H Bacon; Myron J Levin; Jeffry J Leary; Robert T Sarisky; David Sutton
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

7.  High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant.

Authors:  Anthony Griffiths; Donald M Coen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV.

Authors:  Monique van Velzen; Werner J D Ouwendijk; Stacy Selke; Suzan D Pas; Freek B van Loenen; Albert D M E Osterhaus; Anna Wald; Georges M G M Verjans
Journal:  J Med Virol       Date:  2013-06-18       Impact factor: 2.327

Review 9.  Diagnosis of genital herpes simplex virus infection in the clinical laboratory.

Authors:  Jérôme LeGoff; Hélène Péré; Laurent Bélec
Journal:  Virol J       Date:  2014-05-12       Impact factor: 4.099

10.  Recombinant herpes simplex virus type 1 strains with targeted mutations relevant for aciclovir susceptibility.

Authors:  Anne-Kathrin Brunnemann; Kristin Liermann; Stefanie Deinhardt-Emmer; Gregor Maschkowitz; Anja Pohlmann; Beate Sodeik; Helmut Fickenscher; Andreas Sauerbrei; Andi Krumbholz
Journal:  Sci Rep       Date:  2016-07-18       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.